Neomics announces appointment of Dr. Kim Sun-kyu as new director
Published: 2009-04-29 06:56:00
Updated: 2009-04-29 06:56:00
Neomix Co., a local biopharmaceutical firm, has recently announced the appointment of Dr. Kim Sun-kyu (40 years old, photo) as its new director during the shareholder meeting, under the recommendation of Novartis Korea and Norvatis Venture Fund.
Nornatis AG targeted its first Korean biotechnol...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
